Two important pancreatic studies: PRODIGE 24 and PREOPANC
7 Aug 2018
Two important pancreatic studies: PRODIGE 24 and PREOPANC
The PERSEPHONE trial: 6 months and 12 months of trastuzumab in breast cancer
The iManageCancer platform
Patient empowerment through iManageCancer
The 'My Health Avatar' app for iManageCancer
A pilot study for the iManageCancer platform
iManageCancer clinical pilot design and preliminary outcomes
Stephan Kiefer outlines the iManageCancer platform
Apps and mobile games for the cancer community
The role of observational epidemiology in cancer research
The ICMC: a new path for microbiome research
Novas perspectivas sobre dor intercorrente no câncer (BTcP)